LAR, or low anterior resection, is a surgery to remove rectal cancer while preserving the ability to have bowel movements naturally. The surgeon removes the cancerous section of the rectum along with surrounding tissue and lymph nodes, then reconnects the remaining bowel so stool can still pass through the anus. It’s the primary surgical treatment for rectal cancers that haven’t grown into the sphincter muscles, and it carries a five-year overall survival rate above 80% for patients who undergo curative resection.
Who Needs a Low Anterior Resection
LAR is used when a rectal tumor can be fully removed without sacrificing the sphincter muscles that control bowel movements. If the tumor sits above or near the sphincters but isn’t directly invading them, LAR is typically the procedure of choice. Tumors in the lowest third of the rectum, within about 5 centimeters of the sphincter complex, still qualify for LAR as long as the surgeon can achieve a clear margin below the cancer.
When a tumor has grown into the sphincter muscles themselves, LAR is no longer an option. In those cases, surgeons generally perform an abdominoperineal resection (APR), which removes the entire rectum and anus and requires a permanent colostomy bag. The critical distinction is whether the sphincters can be spared. LAR exists specifically to avoid that outcome whenever oncologically safe.
What Happens During the Surgery
The core of LAR is a technique called total mesorectal excision, or TME. The surgeon removes the rectum along with all the fat, blood vessels, and lymph nodes surrounding it in one intact package, wrapped in a natural tissue envelope. Removing this entire package in one piece is what drives outcomes: the completeness of this excision directly predicts the risk of cancer coming back locally and the patient’s long-term survival.
The operation follows a systematic approach. The surgeon first frees the left side of the colon from the abdominal wall, then divides the blood vessels feeding the rectum. Next comes the careful dissection around the rectum itself, working from the back, sides, and front to separate it from surrounding structures like the bladder, prostate, or vagina. The goal throughout is to stay in the correct tissue plane so the entire envelope of tissue around the rectum stays intact.
Once the rectum and cancer are removed, the surgeon reconnects the colon to whatever small segment of rectum remains above the anus, or directly to the top of the anal canal. For connections very close to the anus (within 5 centimeters of the anal opening), surgeons often create a small pouch from the colon to act as a reservoir. This pouch helps reduce bowel frequency from what would otherwise be 3 to 9 movements per day down to roughly 2 to 4.
Most LAR procedures today are done minimally invasively, using either laparoscopic or robotic techniques. Both approaches use small incisions and a camera rather than a large open cut. Robotic surgery has shown slightly fewer complications in matched comparisons, with conversion to open surgery occurring in roughly 0 to 2% of cases with either approach.
The Temporary Stoma
Many patients wake up from LAR with a temporary ileostomy, a small opening in the abdomen where the small intestine is diverted into a bag. This protects the new connection in the rectum while it heals. The decision to create one depends on the patient’s overall health, whether they received radiation before surgery, how low the connection sits, and factors the surgeon observes during the operation like bleeding or a particularly narrow pelvis.
The reason for this detour is straightforward: if the new connection leaks before it heals, the consequences are serious. With a temporary stoma in place, the leak rate drops substantially. Pooled data from randomized trials shows leak rates of about 6% with a diverting stoma compared to 18% without one. The stoma is typically reversed in a second, smaller surgery a few months later once the connection has fully healed.
Hospital Stay and Early Recovery
The median hospital stay after colorectal surgery is now about 4 days, though the average stretches to 7 days because some patients have complications that keep them longer. Enhanced recovery programs, which emphasize early walking, early eating, and minimizing unnecessary tubes and drains, have helped bring these numbers down significantly over the past decade.
In the first weeks at home, your diet plays a meaningful role in comfort. Most patients start with easily digestible foods and gradually reintroduce more variety. Spicy foods, caffeine, alcohol, and citrus tend to worsen bowel symptoms early on and are generally worth avoiding during initial recovery. Some patients also benefit from fiber supplements to improve stool consistency.
Low Anterior Resection Syndrome
The most common long-term challenge after LAR isn’t the cancer itself but changes in bowel function. This collection of symptoms is called low anterior resection syndrome, or LARS, and it affects a large majority of patients. In one study evaluating patients after stoma reversal, 76% developed LARS, with 64% experiencing the more severe form.
LARS includes several interrelated problems: frequent bowel movements, urgent rushes to the bathroom, clustering of multiple bowel movements within a short window, and difficulty controlling gas or loose stool. These symptoms happen because the surgery removes the portion of the rectum that normally stores stool and coordinates the signals that tell you when to go. The remaining bowel needs time to adapt to its new role, and for some patients, that adaptation is incomplete.
Management starts with dietary adjustments. Bulking agents help firm up stool, and pelvic floor physiotherapy strengthens the muscles involved in continence. Medications that slow bowel transit can reduce frequency and urgency. Some patients find that eliminating specific foods makes a noticeable difference. In a recent case series, removing dairy from the diet led to significant symptom improvement within 6 weeks for patients who hadn’t responded to other strategies.
Anastomotic Leak Risk
The most serious surgical complication is an anastomotic leak, where the new connection between the colon and remaining rectum fails to seal properly. The overall leak rate after LAR runs roughly 8 to 10% without a diverting stoma. Male patients face a higher risk, likely because the male pelvis is narrower and makes the surgery technically more difficult. Other risk factors include obesity, malnutrition, steroid use, and prior radiation therapy.
When a leak occurs, it can cause infection, abscess, or sepsis, often requiring additional surgery. This is a major reason surgeons favor creating a temporary stoma for low connections: it doesn’t prevent leaks entirely, but it dramatically reduces their clinical impact.
Long-Term Cancer Outcomes
In a large series of 681 consecutive patients treated at a specialty center, the five-year overall survival rate was 81%, and the disease-free survival rate was 75%. Among those who had curative resections, the overall recurrence rate at five years was 19%. Of those recurrences, 12% were distant (cancer spreading to other organs like the liver or lungs), while 7% involved local recurrence in the pelvis.
These numbers reflect outcomes across all stages of rectal cancer treated with LAR. Earlier-stage cancers carry substantially better odds. Many patients also receive chemotherapy, radiation, or both before or after surgery, which further influences individual outcomes. The local recurrence rate of 7 to 10% represents a major improvement over historical rates before the TME technique became standard, when local recurrence could exceed 30%.